BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33127669)

  • 1. Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche.
    Ma C; Witkowski MT; Harris J; Dolgalev I; Sreeram S; Qian W; Tong J; Chen X; Aifantis I; Chen W
    Sci Adv; 2020 Oct; 6(44):. PubMed ID: 33127669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL.
    Balandrán JC; Dávila-Velderrain J; Sandoval-Cabrera A; Zamora-Herrera G; Terán-Cerqueda V; García-Stivalet LA; Limón-Flores JA; Armenta-Castro E; Rodríguez-Martínez A; Leon-Chavez BA; Vallejo-Ruiz V; Hassane DC; Pérez-Tapia SM; Ortiz-Navarrete V; Guzman ML; Pelayo R
    Front Immunol; 2021; 12():746492. PubMed ID: 34737747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
    Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
    Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.
    Dander E; Palmi C; D'Amico G; Cazzaniga G
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.
    Boyerinas B; Zafrir M; Yesilkanal AE; Price TT; Hyjek EM; Sipkins DA
    Blood; 2013 Jun; 121(24):4821-31. PubMed ID: 23589674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
    Uy GL; Hsu YM; Schmidt AP; Stock W; Fletcher TR; Trinkaus KM; Westervelt P; DiPersio JF; Link DC
    Leuk Res; 2015 Dec; 39(12):1437-42. PubMed ID: 26467815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia.
    Tang C; Li MH; Chen YL; Sun HY; Liu SL; Zheng WW; Zhang MY; Li H; Fu W; Zhang WJ; Liang AB; Tang ZH; Hong DL; Zhou BS; Duan CW
    J Exp Clin Cancer Res; 2018 Aug; 37(1):204. PubMed ID: 30157922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BM-MSCs display altered gene expression profiles in B-cell acute lymphoblastic leukemia niches and exert pro-proliferative effects via overexpression of IFI6.
    Pan C; Hu T; Liu P; Ma D; Cao S; Shang Q; Zhang L; Chen Q; Fang Q; Wang J
    J Transl Med; 2023 Sep; 21(1):593. PubMed ID: 37670388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1/VLA-4.
    Yu K; Yin Y; Ma D; Lu T; Wei D; Xiong J; Zhou Z; Zhang T; Zhang S; Fang Q; Wang J
    Int Immunopharmacol; 2020 Mar; 80():106008. PubMed ID: 31978797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
    Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M
    Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gap Junctions in the Bone Marrow Lympho-Hematopoietic Stem Cell Niche, Leukemia Progression, and Chemoresistance.
    Singh AK; Cancelas JA
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991829
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro simulation of the acute lymphoblastic leukemia niche: a critical view on the optimal approximation for drug testing.
    Pottosin I; Olivas-Aguirre M; Dobrovinskaya O
    J Leukoc Biol; 2023 Jul; 114(1):21-41. PubMed ID: 37039524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia.
    Kim JA; Shim JS; Lee GY; Yim HW; Kim TM; Kim M; Leem SH; Lee JW; Min CK; Oh IH
    Cancer Res; 2015 Jun; 75(11):2222-31. PubMed ID: 25791383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the bone marrow microenvironment in acute leukemia.
    Karantanou C; Godavarthy PS; Krause DS
    Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment.
    Demosthenous C; Lalayanni C; Iskas M; Douka V; Pastelli N; Anagnostopoulos A
    Curr Probl Cancer; 2019 Jun; 43(3):222-227. PubMed ID: 29895435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia propagating cells rebuild an evolving niche in response to therapy.
    Duan CW; Shi J; Chen J; Wang B; Yu YH; Qin X; Zhou XC; Cai YJ; Li ZQ; Zhang F; Yin MZ; Tao Y; Mi JQ; Li LH; Enver T; Chen GQ; Hong DL
    Cancer Cell; 2014 Jun; 25(6):778-93. PubMed ID: 24937459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow recovery of hematopoietic stem cells and microenvironment after chemotherapy in childhood acute lymphoblastic leukemia: consecutive observations according to chemotherapy schedule.
    Park SH; Lee MJ; Park CJ; Jang S; Seo EJ; Im HJ; Seo JJ
    Pediatr Hematol Oncol; 2019 May; 36(4):222-235. PubMed ID: 31313940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-niche microvascularized human bone marrow (hBM) on-a-chip elucidates key roles of the endosteal niche in hBM physiology.
    Nelson MR; Ghoshal D; Mejías JC; Rubio DF; Keith E; Roy K
    Biomaterials; 2021 Mar; 270():120683. PubMed ID: 33556648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells.
    Portale F; Cricrì G; Bresolin S; Lupi M; Gaspari S; Silvestri D; Russo B; Marino N; Ubezio P; Pagni F; Vergani P; Kronnie GT; Valsecchi MG; Locatelli F; Rizzari C; Biondi A; Dander E; D'Amico G
    Haematologica; 2019 Mar; 104(3):533-545. PubMed ID: 30262563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.